期刊文献+

鼻咽癌放疗联合尼妥珠单抗的观察与护理 被引量:4

下载PDF
导出
摘要 [目的]探讨鼻咽癌放疗病人联合静脉使用尼妥珠单抗注射液的护理。[方法]对我科38例鼻咽癌放疗病人使用尼妥珠单抗发生不良反应采取相应的护理措施。[结果]减少和预防了各种并发症发生,提高了疗效。[结论]尼妥珠单抗注射液用于鼻咽癌放疗病人中病人耐受性良好,可顺利完成治疗。
出处 《全科护理》 2009年第35期3223-3224,共2页 Chinese General Practice Nursing
  • 相关文献

同被引文献34

  • 1黄敏.护理干预对肿瘤病人化疗致脱发的防治研究[J].医学理论与实践,2005,18(7):784-785. 被引量:9
  • 2田野,蔡清淟,岑信棠.局部晚期鼻咽癌同期放化疗的疗效分析[J].中华肿瘤杂志,2005,27(7):429-431. 被引量:16
  • 3黄晓东,易俊林,高黎,徐国镇,金晶,杨伟志,卢泰祥,吴少雄,吴仁瑞,胡伟汉,谢伟长,韩非,高远红,高剑铭,潘建基,陈传本,朗锦义,李涛,董昱,付玉彬,樊林,李柏森,黎静,王晓怀,陈炳旭,高献书,张萍,吴湘玮,胡炳强.抗表皮生长因子受体单克隆抗体h—R3联合放疗治疗晚期鼻咽癌的Ⅱ期临床研究[J].中华肿瘤杂志,2007,29(3):197-201. 被引量:99
  • 4Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck [ J ]. Clin Adv Hematol Oncol,2008,6, (10) :742-750.
  • 5Sandra EK. Systemic therapied for squamous cell carcinoma of the head and neck. Seminars Oncol Nurs ,2009,25 ( 3 ) : 183-192.
  • 6Vernham GA, Crowther JA. Head and neck carcinoma-stage at presentation. Clin Otolaryngol Allied Sci, 1994,19 (2) : 120-124.
  • 7Crombet T, Ramos T, Rak J, et al. Antip oliferative, antiangiogenic and proapoptotic activity of a humanized anti-EGFR antibody. Int J Cancer,2002,101 (6) :567.
  • 8Crembet T, Osorin M, Cruz T, et al. Use of the humanized anti- epidermal growth factor receptor monclonal antibody h-R3 in combination with radiother-apy in the treatment of locally advanced head and neck cancer patients. J Clin 0ncol,2004,22(9) :1646.
  • 9David AS, Farrin L, Hull L, et al. Cognitive functioning and disturbances of mood in UK veterans of the Persian Gulf War: a comparative study. Psychol Med, 2002, 32(8):1335-1337.
  • 10Ismail K, Kent K, Brugha T, et al. The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study.BMJ, 2002, 325(7364):576.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部